Zheng-Hong Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zheng-Hong Pan has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
De-Sheng Ning
Guangxi Key Laboratory of Plant Functional Phytochemicals and Sustainable Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin, 541006, China
11 shared publicationsYu-Xia Fu
Guangxi Key Laboratory of Plant Functional Phytochemicals and Sustainable Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin, 541006, China
10 shared publicationsLian-Chun Li
Guangxi Key Laboratory of Plant Functional Phytochemicals and Sustainable Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin, 541006, China
6 shared publications- Lian-Chun Li
Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, China
5 shared publications - De-Sheng Ning
Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, China
4 shared publications Zhi-Qi Zou
Guangxi Key Laboratory of Plant Functional Phytochemicals and Sustainable Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin, 541006, China
4 shared publications
Latest Publications
- 1 February 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 156, 108234
Calliloboapins A-L, diterpenoids from the branches and leaves of Callicarpa loboapiculata and their biological activities
- 1 February 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 156, 108234
Calliloboapins A-L, diterpenoids from the branches and leaves of Callicarpa loboapiculata and their biological activities
- 24 July 2024
- Published by Elsevier in Fitoterapia
- Vol. 177, 106145
Bioactive secondary metabolites isolated from the branches and leaves of Pittosporum pulchrum Gagnep.
- 24 July 2024
- Published by Elsevier in Fitoterapia
- Vol. 177, 106145
Bioactive secondary metabolites isolated from the branches and leaves of Pittosporum pulchrum Gagnep.
- 17 June 2024
- Published by Elsevier in Fitoterapia
- Vol. 177, 106084
Psathrosterols C–E, highly conjugated ergosterol derivatives from Psathyrella rogueiana with anti-inflammatory and immunosuppressive activity
- 17 June 2024
- Published by Elsevier in Fitoterapia
- Vol. 177, 106084
Psathrosterols C–E, highly conjugated ergosterol derivatives from Psathyrella rogueiana with anti-inflammatory and immunosuppressive activity
- 1 March 2023
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 59 (2) , 222-224
A New Phenylethanoid Glycoside from the Stems and Leaves of Passiflora edulis
- 1 March 2023
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 59 (2) , 222-224
A New Phenylethanoid Glycoside from the Stems and Leaves of Passiflora edulis
- 11 February 2023
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 83, 129187
Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives
- 11 February 2023
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 83, 129187
Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives
- 1 January 2023
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 43 (4) , 1591-1595
A New Monoterpene-Phenylpropanoid from Illicium difengpi
- 1 January 2023
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 43 (4) , 1591-1595
A New Monoterpene-Phenylpropanoid from Illicium difengpi
- 29 December 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 305, 116124
The dichloromethane extract of Callicarpa longissima rich in diterpenoid phenols exerts anti-inflammatory effect via inhibiting the TLR4/NF-κB signaling pathway
- 29 December 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 305, 116124
The dichloromethane extract of Callicarpa longissima rich in diterpenoid phenols exerts anti-inflammatory effect via inhibiting the TLR4/NF-κB signaling pathway
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
The Dichloromethane Extract of Callicarpa Longissima Rich in Diterpenoid Phenols Exerts Anti-Inflammatory Effect Via Inhibiting of the TLR4/NF-κB Signaling Pathway
Ethnopharmacological relevance: Callicarpa longissima is a typical Yao ethnomedicine that has been used to treat arthritis in China. Our previous study found that the dichloromethane extract (DCME) of C. longissima showed anti-inflammatory activity in vitro. However, the anti-inflammatory mechanism and detailed chemical composition of DCME remain unclear, which lead to the original interest of this study. Aim of the study: The study aimed to evaluate the anti-inflammatory properties of the DCME from C. longissima and further explore the accurate chemical components responsible for this active extract. Materials and methods: The anti-inflammatory activity of DCME in vivo was tested with carrageenan-induced mice paw edema model. Its anti-inflammatory mechanism was explored with LPS-stimulated RAW264.7 macrophages model. The compounds in DCME were isolated by repeated column chromatography and their structures were identified on the basis of nuclear magnetic resonance spectroscopy. The anti-inflammatory activities of the isolates in vitro were also tested by suppressing releases of inflammatory mediators (NO, IL-6 and TNF-α) in RAW264.7 macrophages model. In addition, the molecular docking analysis, which evaluated the potential interaction between the compounds and Toll-like receptor 4 (TLR4) and nuclear factor κB (NF-κB), was performed. Results: DCME effectively alleviated the mice paw edema induced by carrageenan. In LPS-stimulated RAW264.7 cells, DCME significantly decreased the production of interleukin (IL)-6 and tumor necrosis factor α (TNF-α), down-regulated the expression of TLR4 and myeloid differentiation factor 88, inhibited the phosphorylation of alpha inhibitor of NF-κB (IκBα), NF-κB p65, and degradation of IκBα. Twelve diterpenoid phenols were identified from DCME, and they not only showed different inhibitory effects on the production of NO, IL-6 and TNF-α in LPS-stimulated RAW264.7 cells, but also could bind to TLR4 and NF-κB as analyzed by molecular docking. Conclusions: Taken together, the dichloromethane extract (DCME) from C. longissima could inhibit inflammatory response both in vitro and in vivo, which is mainly attributed to the synergistic effect of abundant diterpenoid phenols through inhibiting the TLR4/NF-κB signaling pathway, and might be a promising agent for the treatment of inflammatory diseases.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe Dichloromethane Extract of Callicarpa Longissima Rich in Diterpenoid Phenols Exerts Anti-Inflammatory Effect Via Inhibiting of the TLR4/NF-κB Signaling Pathway
Ethnopharmacological relevance: Callicarpa longissima is a typical Yao ethnomedicine that has been used to treat arthritis in China. Our previous study found that the dichloromethane extract (DCME) of C. longissima showed anti-inflammatory activity in vitro. However, the anti-inflammatory mechanism and detailed chemical composition of DCME remain unclear, which lead to the original interest of this study. Aim of the study: The study aimed to evaluate the anti-inflammatory properties of the DCME from C. longissima and further explore the accurate chemical components responsible for this active extract. Materials and methods: The anti-inflammatory activity of DCME in vivo was tested with carrageenan-induced mice paw edema model. Its anti-inflammatory mechanism was explored with LPS-stimulated RAW264.7 macrophages model. The compounds in DCME were isolated by repeated column chromatography and their structures were identified on the basis of nuclear magnetic resonance spectroscopy. The anti-inflammatory activities of the isolates in vitro were also tested by suppressing releases of inflammatory mediators (NO, IL-6 and TNF-α) in RAW264.7 macrophages model. In addition, the molecular docking analysis, which evaluated the potential interaction between the compounds and Toll-like receptor 4 (TLR4) and nuclear factor κB (NF-κB), was performed. Results: DCME effectively alleviated the mice paw edema induced by carrageenan. In LPS-stimulated RAW264.7 cells, DCME significantly decreased the production of interleukin (IL)-6 and tumor necrosis factor α (TNF-α), down-regulated the expression of TLR4 and myeloid differentiation factor 88, inhibited the phosphorylation of alpha inhibitor of NF-κB (IκBα), NF-κB p65, and degradation of IκBα. Twelve diterpenoid phenols were identified from DCME, and they not only showed different inhibitory effects on the production of NO, IL-6 and TNF-α in LPS-stimulated RAW264.7 cells, but also could bind to TLR4 and NF-κB as analyzed by molecular docking. Conclusions: Taken together, the dichloromethane extract (DCME) from C. longissima could inhibit inflammatory response both in vitro and in vivo, which is mainly attributed to the synergistic effect of abundant diterpenoid phenols through inhibiting the TLR4/NF-κB signaling pathway, and might be a promising agent for the treatment of inflammatory diseases.
- Open Access
Rosmanol and Carnosol Synergistically Alleviate Rheumatoid Arthritis through Inhibiting TLR4/NF-κB/MAPK Pathway
Callicarpalongissima has been used as a Yao folk medicine to treat arthritis for years in China, although its active anti-arthritic moieties have not been clarified so far. In this study, two natural phenolic diterpenoids with anti-rheumatoid arthritis (RA) effects, rosmanol and carnosol, isolated from the medicinal plant were reported on for the first time. In type II collagen-induced arthritis DBA/1 mice, both rosmanol (40 mg/kg/d) and carnosol (40 mg/kg/d) alone alleviated the RA symptoms, such as swelling, redness, and synovitis; decreased the arthritis index score; and downregulated the serum pro-inflammatory cytokine levels of interleukin 6 (IL-6), monocyte chemotactic protein 1 (MCP-1), and tumor necrosis factor α (TNF-α). Additionally, they blocked the activation of the Toll-like receptor 4 (TLR4)/nuclear factor κB (NF-κB)/c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) pathways. Of particular interest was that when they were used in combination (20 mg/kg/d each), the anti-RA effect and inhibitory activity on the TLR4/NF-κB/MAPK pathway were significantly enhanced. The results demonstrated that rosmanol and carnosol synergistically alleviated RA by inhibiting inflammation through regulating the TLR4/NF-κB/MAPK pathway, meaning they have the potential to be developed into novel, safe natural combinations for the treatment of RA.
Open AccessRosmanol and Carnosol Synergistically Alleviate Rheumatoid Arthritis through Inhibiting TLR4/NF-κB/MAPK Pathway
Callicarpalongissima has been used as a Yao folk medicine to treat arthritis for years in China, although its active anti-arthritic moieties have not been clarified so far. In this study, two natural phenolic diterpenoids with anti-rheumatoid arthritis (RA) effects, rosmanol and carnosol, isolated from the medicinal plant were reported on for the first time. In type II collagen-induced arthritis DBA/1 mice, both rosmanol (40 mg/kg/d) and carnosol (40 mg/kg/d) alone alleviated the RA symptoms, such as swelling, redness, and synovitis; decreased the arthritis index score; and downregulated the serum pro-inflammatory cytokine levels of interleukin 6 (IL-6), monocyte chemotactic protein 1 (MCP-1), and tumor necrosis factor α (TNF-α). Additionally, they blocked the activation of the Toll-like receptor 4 (TLR4)/nuclear factor κB (NF-κB)/c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) pathways. Of particular interest was that when they were used in combination (20 mg/kg/d each), the anti-RA effect and inhibitory activity on the TLR4/NF-κB/MAPK pathway were significantly enhanced. The results demonstrated that rosmanol and carnosol synergistically alleviated RA by inhibiting inflammation through regulating the TLR4/NF-κB/MAPK pathway, meaning they have the potential to be developed into novel, safe natural combinations for the treatment of RA.